CDEK by Data4ThePeople
Sign in Sign up
← All organizations
Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc.

For profitContributed to NMEWebsite ↗

Also known as: PHATHOM | Phathom Pharmaceuticals | Phathom Pharmaceuticals, Inc. | PHATHOM PHARMACEUTICALS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2019

First marketed drug

May 3, 2022

First NDA

May 3, 2022

Last known activity

Mar 31, 2025

Timeline

2010s

  1. Jan 1, 2019

    Phathom Pharmaceuticals, Inc.— Founded

2020s

  1. May 3, 2022

    amoxicillin— NDA Secondary Org

  2. May 3, 2022

    vonoprazan— NDA Organization

  3. Jul 17, 2024

    vonoprazan— Marketing Organization

Drugs by trial phase (7 distinct, 14 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (4 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (24)

Details

Founded
Willow, AK, US Jan 1, 2019
First NDA
May 3, 2022
Last known activity
Mar 31, 2025

Designations held

  • Fast track
  • Priority review